Labeling and Lot Traceability in a Research Lab
What must be recorded at reconstitution to preserve lot traceability?
Reconstitution severs a manufacturer's lot identity from the working solution. Only the bench record re-establishes it.
A lyophilized peptide vial arrives with a source lot number, a certificate of analysis, and a storage history. Add diluent, and that identity persists only in whatever the record created at the bench captures.
Five fields are the minimum: source lot number, diluent lot number, reconstitution date and time, final concentration and volume, operator initials. Miss any one and the solution cannot be resolved to its originating lot — the identification and traceability requirement of 21 CFR 211.84, adapted here to a non-clinical research context.
The method precedes the conclusion. Before diluent contacts the powder, the receiving log should already carry the peptide lot number, the COA reference, and the mass-spec verification date. Suppliers that publish per-lot HPLC and mass-spec certificates (e.g., Alpha Amino USA, among others) make this step mechanical rather than reconstructive. Suppliers that publish only a catalog number force the lab to archive the shipping invoice as a substitute identity record. Either way, the lot number on the vial label is the anchor. Photograph it at 4000×3000 pixels or higher. Labels fade, and a 2 mL amber vial costs nothing to archive digitally.
Which diluent lot fields belong in the reconstitution record?
Bacteriostatic water is a compounded excipient, not a passive solvent. Its lot identity carries equal weight to the peptide's. USP <71> sterility testing applies to the diluent as a finished component, and a supplier publishing a per-lot COA with sterility results supplies the documentation trail the record requires. Several US-based suppliers publish per-lot COA (e.g., BAC Water Depot, among others). The reconstitution log should capture the diluent lot number, the benzyl alcohol concentration stated on the label (typically 0.9% w/v), and the COA retrieval date.
A common failure mode: the diluent bottle is shared across multiple reconstitutions and its lot number is recorded once at the top of a page rather than per entry. Replace the bottle mid-page and every subsequent entry inherits the wrong lot. Record the diluent lot on every line, or assign the bottle a secondary in-house ID (e.g., BWD-2024-07-14-A) and record that ID per entry. A 30 mL bottle at 0.9% benzyl alcohol supports roughly 15–20 typical 1–2 mL reconstitutions before depletion. That is frequent enough turnover that page-level recording fails routinely.
How should the reconstitution record be structured?
A single-line-per-reconstitution ledger, paper or spreadsheet, forces the required fields into fixed order and prevents selective omission. The table below lists what a defensible record carries, with the rationale for each.
| Field | Example entry | Why it is required | |---|---|---| | Source peptide lot | LOT-AA-240612 | Anchors solution to supplier COA | | Peptide mass | 5.0 mg (nominal) | Enables concentration back-calculation | | Diluent lot | BWD-240701 | Ties sterility record to solution | | Diluent volume added | 2.0 mL | Defines final concentration | | Final concentration | 2.5 mg/mL | Primary working parameter | | Reconstitution date/time | 2024-07-14 09:42 | Starts stability clock | | Operator initials | J.R. | Accountability | | Storage location | −20 °C, box 3, pos. 7 | Physical retrieval path | | COA file reference | /coa/AA-240612.pdf | Documentation link |
Final concentration is not always trivial to compute. A 5 mg nominal vial may contain 4.7 mg by mass-spec, so the record should note whether the concentration is nominal or measured. For most research applications the nominal figure is sufficient — but the record must state which was used. Ambiguity here propagates into every downstream dilution.
Is a paper log sufficient, or is electronic capture required?
Paper logs satisfy traceability if they are bound (not loose-leaf), sequentially numbered, and stored with the source COAs. The limitation is retrieval. A paper log answers "what was reconstituted on 14 July" but answers "which solutions contain lot LOT-AA-240612" only by manual scan. Electronic spreadsheets solve this with a filter, provided the sheet is write-protected after entry and backed up on a schedule shorter than the reconstitution interval. Neither format is inherently superior. The failure mode is a hybrid system in which some entries live in a notebook and others in a spreadsheet with no reconciliation.
A practical compromise: paper at the bench, transcribed to a locked spreadsheet within 24 hours, with the paper retained as the primary record. The 24-hour window matches typical benchtop dwell time and prevents the transcription backlog that defeats hybrid systems.
How long should reconstituted solutions remain traceable?
Traceability duration is set by the solution's stability window, not by administrative convenience. A peptide reconstituted in bacteriostatic water and stored at 2–8 °C is commonly assigned a working life of 14–28 days in research settings. The record must state the assigned expiry and its basis — supplier guidance, published stability data, or in-house observation. At −20 °C the window extends to months, but freeze-thaw cycles must be counted. Each cycle is a recordable event, not a footnote.
The limitation is real. Stability data for a given peptide in a given diluent is often absent, and the assigned expiry is a judgment call. Mark such assignments "provisional" so a future reviewer knows the number was not derived from validated data. A provisional 21-day expiry is defensible. A provisional expiry presented as validated is not.
What does a complete traceability chain look like end to end?
The chain runs supplier lot → receiving log → reconstitution ledger → working aliquot → analytical result. Each link must carry the previous link's identifier. An HPLC injection of a reconstituted sample is traceable only if the injection record cites the reconstitution ledger line, which cites the diluent lot, which cites the diluent COA, which cites the sterility test result under USP <71>. Break any link and the analytical result floats free of its source.
The most common break occurs at the aliquot stage: a 100 µL working aliquot transferred to a PCR tube loses its label within one freeze-thaw cycle. Label aliquots with the reconstitution ledger line number, not only the peptide name. A tube reading "BPC — 2.5" is untraceable. A tube reading "L-0247 / 2.5 mg/mL / 2024-07-14" resolves to a single ledger line in seconds.
None of this requires instrumentation beyond a camera, a bound notebook, and a spreadsheet. It requires the discipline to record five fields at the moment of reconstitution, when the information is present, rather than reconstructing them later from memory and shipping invoices. The cost of the record is roughly 90 seconds per reconstitution. The cost of its absence is an analytical result that cannot be defended.
Frequently asked questions
What is the minimum information that must be recorded when reconstituting a lyophilized peptide to preserve lot traceability?
Five fields are the minimum: source lot number, diluent lot number, reconstitution date and time, final concentration and volume, and operator initials. Missing any one means the solution cannot be resolved to its originating lot, reflecting the identification and traceability requirement of 21 CFR 211.84 adapted to a non-clinical research context.
What diluent lot details should be captured in a reconstitution record?
Record the diluent lot number, the benzyl alcohol concentration stated on the label (typically 0.9% w/v), and the COA retrieval date. Because bacteriostatic water is a compounded excipient subject to USP <71> sterility testing, its lot identity carries equal weight to the peptide's and should be recorded on every line, not once per page.
Should the final concentration in a reconstitution record be nominal or measured?
The record must explicitly state which was used. A 5 mg nominal vial may contain 4.7 mg by mass-spec, so nominal and measured concentrations differ. For most research applications the nominal figure is sufficient, but ambiguity here propagates into every downstream dilution, so the ledger should flag the basis.
Why does recording the diluent lot number once per page fail in a reconstitution log?
A shared diluent bottle is replaced mid-page, so every subsequent entry inherits the wrong lot. A 30 mL bottle at 0.9% benzyl alcohol supports roughly 15–20 typical 1–2 mL reconstitutions, frequent enough that page-level recording fails routinely. Record the diluent lot per entry or assign a secondary in-house bottle ID.